Stock AUGX AUGMEDIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Augmedix, Inc.

Equities

AUGX

US05105P1075

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
2.71 USD -4.24% Intraday chart for Augmedix, Inc. -4.58% -53.68%
Apr. 24 Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments CI
Apr. 12 Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024
AQ
Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List
AQ
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
AQ
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
CI
Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing
MT
North American Morning Briefing : Traders Await -2-
DJ
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
AQ
Augmedix, Inc. Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
CI
Augmedix Insider Sold Shares Worth $454,454, According to a Recent SEC Filing
MT
Augmedix Insider Sold Shares Worth $380,108, According to a Recent SEC Filing
MT
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
AQ
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
CI
Top Midday Gainers
MT
Evercore ISI Adjusts Price Target on Augmedix to $4.50 From $6.50, Maintains In-Line Rating
MT
Augmedix Shares Surge 15% Premarket Tuesday as Revenue Growth Beats Expectations, Gross Margins Expand in Q4
MT
Transcript : Augmedix, Inc., Q4 2023 Earnings Call, Mar 18, 2024
Earnings Flash (AUGX) AUGMEDIX Reports Q4 Revenue $12.7M, vs. Street Est of $12.4M
MT
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
AQ
Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Augmedix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AUGX Stock
  4. News Augmedix, Inc.